Cite

    Zhu, W. et al. (n.d.). Activity of pemetrexed-based regimen as first-line chemotherapy for advanced non-small cell lung cancer with asymptomatic inoperable brain metastasis: a retrospective study. Journal of chemotherapy. pp. 221-226. [Online].